Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
That differs from single-dose autoinjector pens, the currently available form of all Zepbound doses, which patients can directly inject under their skin with the click of a button. Eli Lilly has ...
The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...
A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...
Investing.com - Eli Lilly (NYSE ... at a roughly $150 discount to its injector pen versions. Shares in the group edged higher in early U.S. trading. Lilly said in a statement that patients could ...
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback